BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37276272)

  • 1. Do investments in cancer registry databases and tools bring added value? NORDCAN as an example.
    Storm HH; Larønningen S; Bray F
    Acta Oncol; 2023 Jun; 62(6):535-540. PubMed ID: 37276272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nordcan.R: a new tool for federated analysis and quality assurance of cancer registry data.
    Larønningen S; Skog A; Engholm G; Ferlay J; Johannesen TB; Kristiansen MF; Knoors D; Kønig SM; Olafsdottir EJ; Pejicic S; Pettersson D; Skovlund CW; Storm HH; Tian H; Aagnes B; Miettinen J
    Front Oncol; 2023; 13():1098342. PubMed ID: 37614501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NORDCAN--a Nordic tool for cancer information, planning, quality control and research.
    Engholm G; Ferlay J; Christensen N; Bray F; Gjerstorff ML; Klint A; Køtlum JE; Olafsdóttir E; Pukkala E; Storm HH
    Acta Oncol; 2010 Jun; 49(5):725-36. PubMed ID: 20491528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival trends in patients diagnosed with colon and rectal cancer in the nordic countries 1990-2016: The NORDCAN survival studies.
    Lundberg FE; Birgisson H; Johannesen TB; Engholm G; Virtanen A; Pettersson D; Ólafsdóttir EJ; Lambe M; Lambert PC; Mørch LS; Johansson ALV; Andersson TM
    Eur J Cancer; 2022 Sep; 172():76-84. PubMed ID: 35759813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time trends and occupational variation in the incidence of testicular cancer in the Nordic countries.
    Ylönen O; Jyrkkiö S; Pukkala E; Syvänen K; Boström PJ
    BJU Int; 2018 Sep; 122(3):384-393. PubMed ID: 29460991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies.
    Lundberg FE; Andersson TM; Lambe M; Engholm G; Mørch LS; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Johansson ALV; Lambert PC
    Acta Oncol; 2020 Nov; 59(11):1266-1274. PubMed ID: 33073632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter Re: Survival trends in solid cancers in the Nordic countries through 50 years: Proper referencing is necessary when using free-of-charge online cancer statistics resources, like NORDCAN.
    Larønningen S; Storm HH
    Eur J Cancer; 2023 Apr; 183():188-189. PubMed ID: 36797103
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016: The NORDCAN survival studies.
    Lundberg FE; Birgisson H; Engholm G; Ólafsdóttir EJ; Mørch LS; Johannesen TB; Pettersson D; Lambe M; Seppä K; Lambert PC; Johansson ALV; Hölmich LR; Andersson TM
    Eur J Cancer; 2024 May; 202():113980. PubMed ID: 38452724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer in the Faroe Islands from 1960-2019 - incidence, mortality, and comparisons with the other Nordic countries.
    Kristiansen MF; Mikkelsen RM; Kristiansdóttir T; Rasmussen P; Andórsdóttir G; Hansen SÓ; Nielsen KR; Á Steig B; Strøm M; Petersen MS
    Acta Oncol; 2022 Aug; 61(8):907-915. PubMed ID: 35657096
    [No Abstract]   [Full Text] [Related]  

  • 11. Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021.
    Johansson ALV; Kønig SM; Larønningen S; Engholm G; Kroman N; Seppä K; Malila N; Steig BÁ; Gudmundsdóttir EM; Ólafsdóttir EJ; Lundberg FE; Andersson TM; Lambert PC; Lambe M; Pettersson D; Aagnes B; Friis S; Storm H
    Acta Oncol; 2024 Apr; 63():179-191. PubMed ID: 38597666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific survival trends and life-years lost in women with breast cancer 1990-2016: the NORDCAN survival studies.
    Lundberg FE; Kroman N; Lambe M; Andersson TM; Engholm G; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Lambert PC; Mørch LS; Johansson ALV
    Acta Oncol; 2022 Dec; 61(12):1481-1489. PubMed ID: 36542678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results.
    Storm HH; Engholm G; Hakulinen T; Tryggvadóttir L; Klint A; Gislum M; Kejs AM; Bray F
    Acta Oncol; 2010 Jun; 49(5):532-44. PubMed ID: 20491522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nordic perioperative and intensive care registries-Collaboration and research possibilities.
    Kvåle R; Möller MH; Porkkala T; Varpula T; Enlund G; Engerstrôm L; Sigurdsson MI; Thormar K; Garde K; Christensen S; Buanes EA; Sverrisson K
    Acta Anaesthesiol Scand; 2023 Aug; 67(7):972-978. PubMed ID: 37096912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer survival in the Faroe Islands over the last 50 years compared to the other Nordic countries.
    Kristiansen MF; Mikkelsen RM; Kristiansdóttir T; Andórsdóttir G; Hansen SÓ; Á Steig B; Nielsen KR; Skaalum Petersen M; Strøm M
    Int J Cancer; 2023 May; 152(10):2090-2098. PubMed ID: 36727543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-related costs should be allocated in a comparable way-benchmarking costs of cancer in Nordic countries 2012-2017.
    Torkki P; Leskelä RL; Bugge C; Torfadottir JE; Karjalainen S
    Acta Oncol; 2022 Oct; 61(10):1216-1222. PubMed ID: 36151990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019.
    Karttunen E; Hervonen P; Hosseini Aliabad A; Oldenburg J; Pappot H; Sairanen J; Støvring H; Vásquez JL; Bergman S; Magnussen G; Norremark P; Thoresen S; Ullén A
    Scand J Urol; 2023; 57(1-6):15-21. PubMed ID: 36416403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
    Engholm G; Gislum M; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nordic Cancer Registries - an overview of their procedures and data comparability.
    Pukkala E; Engholm G; Højsgaard Schmidt LK; Storm H; Khan S; Lambe M; Pettersson D; Ólafsdóttir E; Tryggvadóttir L; Hakanen T; Malila N; Virtanen A; Johannesen TB; Larønningen S; Ursin G
    Acta Oncol; 2018 Apr; 57(4):440-455. PubMed ID: 29226751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of cancer: a review of the available data.
    Zanetti R; Micheli A; Rosso S; Sant M
    Tumori; 1999; 85(5):408-13. PubMed ID: 10665858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.